These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 17236253)
1. Mimotopes selected with antibodies from HIV-1-neutralizing long-term non-progressor plasma. Humbert M; Antoni S; Brill B; Landersz M; Rodes B; Soriano V; Wintergerst U; Knechten H; Staszewski S; von Laer D; Dittmar MT; Dietrich U Eur J Immunol; 2007 Feb; 37(2):501-15. PubMed ID: 17236253 [TBL] [Abstract][Full Text] [Related]
2. Antibodies to conserved epitopes of the HIV-1 envelope in sera from long-term non-progressors: prevalence and association with neutralizing activity. Braibant M; Brunet S; Costagliola D; Rouzioux C; Agut H; Katinger H; Autran B; Barin F AIDS; 2006 Oct; 20(15):1923-30. PubMed ID: 16988513 [TBL] [Abstract][Full Text] [Related]
3. Mimotopes selected by biopanning with high-titer HIV-neutralizing antibodies in plasma from Chinese slow progressors. Zhang X; Han X; Dai D; Bao M; Zhang Z; Zhang M; Bice T; Zhao M; Cao Y; Shang H Braz J Infect Dis; 2012; 16(6):510-6. PubMed ID: 23141970 [TBL] [Abstract][Full Text] [Related]
5. 3D-Epitope-Explorer (3DEX): localization of conformational epitopes within three-dimensional structures of proteins. Schreiber A; Humbert M; Benz A; Dietrich U J Comput Chem; 2005 Jul; 26(9):879-87. PubMed ID: 15834923 [TBL] [Abstract][Full Text] [Related]
6. High level serum neutralizing antibody against HIV-1 in Chinese long-term non-progressors. Wang Q; Shang H; Han X; Zhang Z; Jiang Y; Wang Y; Dai D; Diao Y Microbiol Immunol; 2008 Apr; 52(4):209-15. PubMed ID: 18426395 [TBL] [Abstract][Full Text] [Related]
7. Molecular characterization of the circulating anti-HIV-1 gp120-specific B cell repertoire using antibody phage display libraries generated from pre-selected HIV-1 gp120 binding PBLs. Koefoed K; Farnaes L; Wang M; Svejgaard A; Burton DR; Ditzel HJ J Immunol Methods; 2005 Feb; 297(1-2):187-201. PubMed ID: 15777942 [TBL] [Abstract][Full Text] [Related]
8. Collection of phage-peptide probes for HIV-1 immunodominant loop-epitope. Palacios-RodrÃguez Y; Gazarian T; Rowley M; Majluf-Cruz A; Gazarian K J Microbiol Methods; 2007 Feb; 68(2):225-35. PubMed ID: 17046088 [TBL] [Abstract][Full Text] [Related]
9. Selection of HIV-specific immunogenic epitopes by screening random peptide libraries with HIV-1-positive sera. Scala G; Chen X; Liu W; Telles JN; Cohen OJ; Vaccarezza M; Igarashi T; Fauci AS J Immunol; 1999 May; 162(10):6155-61. PubMed ID: 10229859 [TBL] [Abstract][Full Text] [Related]
10. HIV-1 V3 loop crown epitope-focused mimotope selection by patient serum from random phage display libraries: implications for the epitope structural features. Gazarian KG; Palacios-RodrÃguez Y; Gazarian TG; Huerta L Mol Immunol; 2013 Jun; 54(2):148-56. PubMed ID: 23270686 [TBL] [Abstract][Full Text] [Related]
11. Design of immunogens that present the crown of the HIV-1 V3 loop in a conformation competent to generate 447-52D-like antibodies. Chakraborty K; Durani V; Miranda ER; Citron M; Liang X; Schleif W; Joyce JG; Varadarajan R Biochem J; 2006 Nov; 399(3):483-91. PubMed ID: 16827663 [TBL] [Abstract][Full Text] [Related]
12. [Selection and recombinant expression of an immunodominant B cell epitope of HIV gp41]. Du Y; Xu J; Li J; Hou L; Wang H Wei Sheng Wu Xue Bao; 2000 Jun; 40(3):270-6. PubMed ID: 12548991 [TBL] [Abstract][Full Text] [Related]
13. Characterization of neutralizing antibodies and identification of neutralizing epitope mimics on the Clostridium botulinum neurotoxin type A. Wu HC; Yeh CT; Huang YL; Tarn LJ; Lung CC Appl Environ Microbiol; 2001 Jul; 67(7):3201-7. PubMed ID: 11425742 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of a synthetic vaccine construct as antigen for the detection of HIV-induced humoral responses. Hewer R; Meyer D Vaccine; 2005 Mar; 23(17-18):2164-7. PubMed ID: 15755588 [TBL] [Abstract][Full Text] [Related]
16. Identifiable biomarker and treatment development using HIV-1 long term non-progressor sera. Hao Y; Bai G; Wang J; Zhao L; Sutherland K; Cai J; Cao C BMC Immunol; 2015 Apr; 16():25. PubMed ID: 25927639 [TBL] [Abstract][Full Text] [Related]
17. The role of neutralizing antibodies in HIV infection. Humbert M; Dietrich U AIDS Rev; 2006; 8(2):51-9. PubMed ID: 16848273 [TBL] [Abstract][Full Text] [Related]
18. Ex vivo neutralization of HIV-1 quasi-species by a broadly reactive humanized monoclonal antibody KD-247. Matsushita S; Takahama S; Shibata J; Kimura T; Shiozaki K; Eda Y; Koito A; Murakami T; Yoshimura K Hum Antibodies; 2005; 14(3-4):81-8. PubMed ID: 16720978 [TBL] [Abstract][Full Text] [Related]
19. Unravelling the antigenic landscape of the HIV-1 subtype A envelope of an individual with broad cross-neutralizing antibodies using phage display peptide libraries. Dieltjens T; Willems B; Coppens S; Van Nieuwenhove L; Humbert M; Dietrich U; Heyndrickx L; Vanham G; Janssens W J Virol Methods; 2010 Oct; 169(1):95-102. PubMed ID: 20637241 [TBL] [Abstract][Full Text] [Related]
20. [Identification of human monoclonal HIV-1-neutralizing antibodies from phage antibody library by cell-based screening]. Zhang N; Man L; Sun JP; Meng JZ; He YX Bing Du Xue Bao; 2013 Sep; 29(5):471-9. PubMed ID: 24386834 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]